At UCB we understand that to truly comprehend the lived experiences of the HS community, patient engagement must be an ongoing commitment ... At UCB, we see this sustained partnership as critical to ensuring progress in HS.
). Today, I experienced a memorable day on our Braine campus in Belgium... Changing lives from lab to patient ... Where science meets scale ... UCB SA published this content on April 24, 2026, and is solely responsible for the information contained herein.
At the same time, initiatives such as the Fracture Liaison ServiceAcademy & Network (FAN), established by UCB and Amgen, are helping to translate this progress into practice ... UCB SA published this ...
Acquisition builds on UCB’s 30-year heritage and leadership as an innovator in epilepsy and accelerates entry into next generation disease-modifying therapies ... “For more than 30 years, UCB has helped shape the modern epilepsy landscape.
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with ...
Brussels (Belgium) 15 APRIL 2026, 07.00 (CEST) – UCB (Euronext Brussels. UCB), a global biopharmaceutical company, today presented new global, real-world, patient-centric data, including data from a ...
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with ...
ATLANTA, April 13, 2026 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced data from two clinical studies assessing ZLP-AI in adult patients who are anti-AChR antibody positivegMG as well as in healthy volunteers ... UCB). .
One of the aims of UCB's recent survey of 489 caregivers to people living with DEEs was to shine a light on the issues surrounding sleep ... UCB SA published this content on April 10, 2026, and is solely responsible for the information contained herein.